Results 71 to 80 of about 326 (156)

Older People in Emergencies; Addressing Food Insecurity, Health Status and Quality of Life: Evaluating the "365+ Days of Care" Program. [PDF]

Int J Environ Res Public Health, 2023
Diamantis DV, Katsas K, Kastorini CM, Mugford L, Dalma N, Ramizi M, Papapanagiotou O, Veloudaki A, Linos A, Kouvari M.   +9 more
europepmc   +1 more source

Predictive Factors for Neutralizing Antibody Levels Nine Months after Full Vaccination with BNT162b2: Results of a Machine Learning Analysis. [PDF]

Biomedicines, 2022
Papadopoulos D, Ntanasis-Stathopoulos I, Gavriatopoulou M, Evangelakou Z, Malandrakis P, Manola MS, Gianniou DD, Kastritis E, Trougakos IP, Dimopoulos MA, Karalis V, Terpos E.   +11 more
europepmc   +1 more source

MİLLÎ MÜCADELE’DE KARADENİZ’DE ZAPT EDİLEN YUNAN ENOSİS VAPURU

Karadeniz İncelemeleri Dergisi
Bu çalışma, Ankara Hükümeti’nin Kurtuluş Savaşı’nda Karadeniz’de zapt ettiği Yunan bandıralı Enosis vapuruyla ilgilidir. Yunanistan’ın, Batı Anadolu’da karadan ilerlemesi ve Türkler tarafından bozguna uğratılması üzerine yapılmış çalışmalara ilaveten, aynı süreçte Karadeniz’de cereyan hadiselerin bir bölümünün ortaya çıkarılması hedeflenmiştir.
openaire   +1 more source

Bayesian Tracking of Emerging Epidemics Using Ensemble Optimal Statistical Interpolation (EnOSI)

, 2010
15 pages, 5 figures.
Krishnamurthy, Ashok, Cobb, Loren, Mandel, Jan, Beezley, Jonathan   +3 more
openaire   +2 more sources

Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study. [PDF]

Ther Adv Hematol, 2022
Diamantopoulos PT, Stafylidis C, Vlachopoulou D, Kontandreopoulou CN, Giannakopoulou N, Vardaka M, Mpouhla A, Mastrogianni E, Variami E, Galanopoulos A, Pappa V, Psichogiou M, Hatzakis A, Viniou NA.   +13 more
europepmc   +1 more source

Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine. [PDF]

Clin Exp Med, 2022
Gavriatopoulou M, Terpos E, Kastritis E, Briasoulis A, Gumeni S, Ntanasis-Stathopoulos I, Sklirou AD, Malandrakis P, Eleutherakis-Papaiakovou E, Migkou M, Trougakos IP, Dimopoulos MA.   +11 more
europepmc   +1 more source

Optical nonlinearity goes ultrafast in 2D semiconductor-based nanocavities. [PDF]

Light Sci Appl, 2022
Genco A, Cerullo G.
europepmc   +1 more source

Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors. [PDF]

J Hematol Oncol, 2021
Terpos E, Zagouri F, Liontos M, Sklirou AD, Koutsoukos K, Markellos C, Briasoulis A, Papanagnou ED, Trougakos IP, Dimopoulos MA.   +9 more
europepmc   +1 more source

Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers. [PDF]

Cells, 2021
Terpos E, Trougakos IP, Karalis V, Ntanasis-Stathopoulos I, Gumeni S, Apostolakou F, Sklirou AD, Gavriatopoulou M, Skourti S, Kastritis E, Korompoki E, Papassotiriou I, Dimopoulos MA.   +12 more
europepmc   +1 more source

Flow Cytometry, a Unique Biotechnology in Medical Applications. [PDF]

J Clin Med, 2022
Lambert C.
europepmc   +1 more source